These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16643774)

  • 21. Human cytomegalovirus latent infection and associated viral gene expression.
    Slobedman B; Cao JZ; Avdic S; Webster B; McAllery S; Cheung AK; Tan JC; Abendroth A
    Future Microbiol; 2010 Jun; 5(6):883-900. PubMed ID: 20521934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts.
    Emery VC; Hassan-Walker AF; Burroughs AK; Griffiths PD
    J Infect Dis; 2002 Jun; 185(12):1723-8. PubMed ID: 12085317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent strategies in the development of new human cytomegalovirus inhibitors.
    Martinez A; Castro A; Gil C; Perez C
    Med Res Rev; 2001 May; 21(3):227-44. PubMed ID: 11301412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview of letermovir: a cytomegalovirus prophylactic option.
    Gerna G; Lilleri D; Baldanti F
    Expert Opin Pharmacother; 2019 Aug; 20(12):1429-1438. PubMed ID: 31282759
    [No Abstract]   [Full Text] [Related]  

  • 25. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
    Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
    Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication.
    Wildum S; Zimmermann H; Lischka P
    Antimicrob Agents Chemother; 2015; 59(6):3140-8. PubMed ID: 25779572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.
    Fu M; Gao Y; Zhou Q; Zhang Q; Peng Y; Tian K; Wang J; Zheng X
    Gene; 2014 Feb; 536(2):272-8. PubMed ID: 24361963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytomegaloviruses--clinical aspects and therapy].
    Hamprecht K; Jahn G
    Ther Umsch; 1994 Aug; 51(8):551-7. PubMed ID: 7940412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
    Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. U
    Goodwin CM; Schafer X; Munger J
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.
    Bruno F; Fornara C; Zelini P; Furione M; Carrara E; Scaramuzzi L; Cane I; Mele F; Sallusto F; Lilleri D; Gerna G
    J Gen Virol; 2016 Aug; 97(8):1928-1941. PubMed ID: 27113912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cytomegalovirus-encoded MicroRNAs: A master regulator of latent infection.
    Abdalla AE; Mahjoob MO; Abosalif KOA; Ejaz H; Alameen AAM; Elsaman T
    Infect Genet Evol; 2020 Mar; 78():104119. PubMed ID: 31740397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Zinc Finger Antiviral Protein ZAP Restricts Human Cytomegalovirus and Selectively Binds and Destabilizes Viral
    Gonzalez-Perez AC; Stempel M; Wyler E; Urban C; Piras A; Hennig T; Ganskih S; Wei Y; Heim A; Landthaler M; Pichlmair A; Dölken L; Munschauer M; Erhard F; Brinkmann MM
    mBio; 2021 May; 12(3):. PubMed ID: 33947766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring human cytomegalovirus infection in transplant recipients.
    Baldanti F; Lilleri D; Gerna G
    J Clin Virol; 2008 Mar; 41(3):237-41. PubMed ID: 18203657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients.
    Gabanti E; Lilleri D; Scaramuzzi L; Zelini P; Rampino T; Gerna G
    New Microbiol; 2018 Jul; 41(3):195-202. PubMed ID: 30028473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy.
    Brestrich G; Zwinger S; Roemhild A; Noutsias M; Rohde M; Keeren K; Sawitzki B; Volk HD; Reinke P; Hammer MH
    J Immunother; 2009; 32(9):932-40. PubMed ID: 19816188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T; Dunne J; Crowley B
    J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of interstitial pneumonia with human cytomegalovirus-induced lung infection and graft-versus-host disease after bone marrow transplantation.
    Müller CA; Hebart H; Roos A; Roos H; Steidle M; Einsele H
    Med Microbiol Immunol; 1995 Oct; 184(3):115-21. PubMed ID: 8577311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
    Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.